MORE controversy about using pioglitazone (Actos) for type 2 diabetes

New generics plus bladder cancer concerns mean you'll hear MORE controversy about using pioglitazone (Actos) for type 2 diabetes.

Actos is one of the top 25 prescribed drugs in the U.S...and lower prices for the generic could tempt more prescribers to use it.

But some providers are reluctant to use it...due to growing concerns about bladder cancer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote